Tradewinds Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Tradewinds Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12	Closed	-$1K	–	660
2018 Q2	$1K	Hold	12	–	–	﹤0.01%	608
2018 Q1	$1K	Hold	12	–	–	﹤0.01%	611
2017 Q4	$1K	Buy	+12	New	+$658	﹤0.01%	640
2016 Q2	–	Sell	-170	Closed	-$7K	–	649
2016 Q1	$7K	Hold	170	–	–	﹤0.01%	431
2015 Q4	$11K	Hold	170	–	–	0.01%	368
2015 Q3	$7K	Hold	170	–	–	0.01%	403
2015 Q2	$10K	Buy	170 +70	+70%	+$4.45K	0.01%	406
2015 Q1	$6K	Sell	100 -10	-9%	-$678	﹤0.01%	432
2014 Q4	$7K	Buy	+110	New	+$5.43K	0.01%	420

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Tradewinds Capital Management's IONS Position: Q3 2018 in Review

Tradewinds Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2018, closing a stake of 12 shares — an estimated $1K sold.

Tradewinds Capital Management first reported a position in IONS in Q4 2014 and held it in 9 quarters. The position peaked at $11K in Q4 2015. 322 funds tracked by Wall St. Rank hold IONS as of Q3 2018.

Tradewinds Capital Management reported no remaining Ionis Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Tradewinds Capital Management sold 12 Ionis Pharmaceuticals shares in Q3 2018, an estimated $1K.
Tradewinds Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 9 quarters.
Tradewinds Capital Management's Ionis Pharmaceuticals position peaked at $11K in Q4 2015.
322 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2018.

Based on Tradewinds Capital Management's 13F filing for Q3 2018, filed 31 Oct 2018.